-
Recent posts
- Pandemic Agreement at last April 17, 2025
- Honouring Dr Olle Hansson April 9, 2025
- Vale Sidney Wolfe January 10, 2024
- HAIAP Forum Penang May 27-28 2023 June 1, 2023
- Dr Zafrullah Chowdhury 1941 – April 11, 2023 April 13, 2023
Archives
- April 2025
- January 2024
- June 2023
- April 2023
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- November 2021
- September 2021
- June 2021
- April 2021
- February 2021
- November 2020
- October 2020
- September 2020
- June 2020
- May 2020
- April 2020
- February 2020
- November 2019
- May 2019
- April 2019
- February 2019
- January 2019
- December 2018
- November 2018
- April 2018
- March 2018
- December 2017
- November 2017
- October 2017
- September 2017
- June 2017
- May 2017
- December 2016
- November 2016
- October 2016
- August 2016
- June 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
Author Archives: Beverley Snell
GSK China fined record sum
(Published 22 September 2014) Cite this as: BMJ 2014;349:g5799 Jane Parry GlaxoSmithKline’s China operation has been fined $488 million after being found guilty of bribery by the Changsha Intermediate People’s Court in Hunan province. In the closed door trial, which … Continue reading
Posted in Uncategorized
Leave a comment
Public health in danger with move of pharmaceutical policy to DG Enterprise and Industry
12 September, 2014 www.haieurope.org Health Action International is appalled by the European Commission’s opaque and unjustified decision to move SANCO Units D5 (Medicinal Products–Authorisations, European Medicines Agency) and D6 (Medicinal Products–Quality, Safety and Efficacy) from the Directorate General (DG) for … Continue reading
Posted in Uncategorized
Leave a comment
Falsified medicines in Africa: all talk, no action
Paul N Newton et al The Lancet Global Health, Volume 2, Issue 9, Pages e509 – e510, September 2014 Poor-quality medicines and medical products, both substandard and falsified, cause avoidable morbidity, mortality, drug resistance, and loss of faith in health systems, … Continue reading
Posted in Uncategorized
Leave a comment
Declaring all – Jane McCredie in MJAInsight
From MJAInsight, Monday August 25, 2014 Medical researchers are rightly required to declare potential financial conflicts of interest when they publish their results, but what of other, more personal, factors that might lead to bias in their findings? Should, for … Continue reading
Posted in Uncategorized
Leave a comment
Doctors under the influence
From Zoe Stewart in MJAInsight, Monday, 25 August, 2014 A recent research article found that medical students and junior doctors exposed to information from pharmaceutical companies were more likely to refer to drugs using their brand names. The authors used a survey to … Continue reading
Posted in Uncategorized
Leave a comment
WHO and partners launch Ebola response plan
A multimillion dollar international strategy to bring west Africa’s Ebola outbreak under control was launched by WHO and countries last week. www.thelancet.com Vol 384 August 9, 2014 Read more here Frequently asked questions here
Posted in Uncategorized
Leave a comment
AIDS 2014 Melbourne, July 20-25
Friday July 25, 2014 – AIDS 2014, the 20th International AIDS Conference ended in Melbourne, Australia with a chorus of international figures calling on governments and organisations to step up the pace in terms of delivering universal access to treatment, … Continue reading
Posted in Uncategorized
Leave a comment
Malaysia: Anti-TPPA movement to come out with book on the controversial agreement
Source: http://www.themalaysianinsider.com/malaysia/article/anti-tppa-movement-to-comeout-with-book-on-the-controversial-agreement#sthash.VdvccdgO.dpuf 10 July 2014 Malaysia’s anti-Trans Pacific Partnership Agreement (TPPA) movement is putting out a book as part of its protest against the pact despite confirmation from Putrajaya that Malaysia would go ahead with the controversial Pacific Rim trade … Continue reading
Posted in Uncategorized
Leave a comment
The Trans Pacific Partnership Agreement: Implications for Access to Medicines and Public Health – UNITAID
Final Report UNITAID March 2014 Through this analysis of provisions that are proposed in the context of the Trans-Pacific Partnership Agreement negotiations, UNITAID seeks to better understand current and future issues in trade negotiations and their impact on access to … Continue reading
Posted in Uncategorized
Leave a comment
TPP – Failure to agree again
Little to gain and much to lose in the Trans-Pacific Partnership (TPP) By Jemma Williams Trade Ministers from 12 countries around the Pacific Rim met once again in Singapore on May 19-20. Their aim was a breakthrough in negotiations towards the … Continue reading
Posted in Uncategorized
Leave a comment